|
CDKN1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.38550001974147E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.31219990008003E-10 |
| Normal-vs-Stage2 |
6.582500E-03 |
| Normal-vs-Stage3 |
3.002400E-02 |
| Normal-vs-Stage4 |
3.984400E-02 |
| Stage1-vs-Stage2 |
6.948200E-01 |
| Stage1-vs-Stage3 |
1.156460E-02 |
| Stage1-vs-Stage4 |
1.110050E-02 |
| Stage2-vs-Stage3 |
9.350400E-02 |
| Stage2-vs-Stage4 |
9.682400E-02 |
| Stage3-vs-Stage4 |
9.996400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30689994779243E-09 |
| Normal-vs-AfricanAmerican |
5.444100E-02 |
| Normal-vs-Asian |
2.371400E-01 |
| Caucasian-vs-AfricanAmerican |
5.871600E-01 |
| Caucasian-vs-Asian |
8.445800E-01 |
| AfricanAmerican-vs-Asian |
7.163200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36519999749396E-08 |
| Normal-vs-Female |
1.630890E-04 |
| Male-vs-Female |
5.558800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.028800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.05560004970818E-09 |
| Normal-vs-Age(61-80Yrs) |
1.198570E-04 |
| Normal-vs-Age(81-100Yrs) |
1.756800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.805620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.430800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.702200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.336350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.679800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.998400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.802440E-03 |
| Normal-vs-Grade 2 |
8.38979996586886E-11 |
| Normal-vs-Grade 3 |
3.035500E-04 |
| Normal-vs-Grade 4 |
8.268800E-01 |
| Grade 1-vs-Grade 2 |
1.677380E-01 |
| Grade 1-vs-Grade 3 |
2.595500E-03 |
| Grade 1-vs-Grade 4 |
2.30589999999919E-05 |
| Grade 2-vs-Grade 3 |
1.801080E-03 |
| Grade 2-vs-Grade 4 |
3.22380000028488E-07 |
| Grade 3-vs-Grade 4 |
1.005770E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.22044604925031E-16 |
| Normal-vs-ccB subtype |
8.296000E-01 |
| ccA subtype-vs-ccB subtype |
2.78665979180914E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68452000000041E-05 |
| Normal-vs-N1 |
5.869200E-01 |
| N0-vs-N1 |
1.074380E-02 |
|
|
